Beer and prevention: new study tests alcohol counseling to boost HIV drug adherence

NCT ID NCT06036238

Ongoing Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether a brief alcohol counseling program helps high-risk adults who drink heavily stay on HIV prevention medication (PrEP or PEP). Researchers will enroll 400 people at drinking venues in Kenya and Uganda, giving half the counseling and half standard care. They will track how long participants stick with their prevention meds over 24 and 48 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Healthy Living Intervention (HLI) - a brief alcohol counseling program
What this could lead to: If successful, this could show that adding alcohol counseling helps people with heavy drinking stay on HIV prevention medication, reducing new infections.
What could go wrong: This is a behavioral study with 400 participants, so results may not apply broadly. Adherence depends on many factors, and the counseling may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Alcohol Drinking HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS

Contacts and locations

Locations

Infectious Diseases Research Collaboration (IDRC)

Mbarara, Uganda
Kenya Medical Research Institute (KEMRI)

Mbita, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.